N-terminal pro-B-type natriuretic peptide and stroke risk: The reasons for geographic and racial differences in stroke cohort

Stroke

Volumn 45, Issue 6, 2014, Pages 1646-1650

  Cushman, Mary ^a   Judd, Suzanne E ^b   Howard, Virginia J ^b   Kissela, Brett ^c   Gutiérrez, Orlando M ^b   Jenny, Nancy S ^a   Ahmed, Ali ^b,d   Thacker, Evan L ^b   Zakai, Neil A ^a  

^a UNIVERSITY OF VERMONT   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

natriuretic peptides; risk factors; stroke

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGE; AGED; ALBUMINURIA; ARTICLE; BRAIN ISCHEMIA; CARDIOEMBOLIC STROKE; CEREBROVASCULAR ACCIDENT; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HEART DISEASE; HEART FAILURE; HEART FUNCTION; HUMAN; HYPERTENSION; KIDNEY DISEASE; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; MEDICAL GEOGRAPHY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RACE DIFFERENCE; RISK FACTOR; SMOKING;

NATRIURETIC PEPTIDES; RISK FACTORS; STROKE;

AGE FACTORS; AGED; AGED, 80 AND OVER; ATRIAL FIBRILLATION; BIOLOGICAL MARKERS; CONTINENTAL POPULATION GROUPS; CORONARY ARTERY DISEASE; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE; HUMANS; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; RETROSPECTIVE STUDIES; SEX FACTORS; STROKE;

EID: 84901932624     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/STROKEAHA.114.004712     Document Type: Article

References (30)

1. Silvet H, Young-Xu Y, Walleigh D, Ravid S. Brain natriuretic pep-tide is elevated in outpatients with atrial fbrillation. Am J Cardiol. 2003;92:1124-1127.
2. Patton KK, Ellinor PT, Heckbert SR, Christenson RH, DeFilippi C, Gottdiener JS, et al. N-terminal pro-B-type natriuretic peptide is a major predictor of the development of atrial fbrillation: the Cardiovascular Health Study. Circulation. 2009;120:1768-1774.
3. Schnabel RB, Larson MG, Yamamoto JF, Sullivan LM, Pencina MJ, Meigs JB, et al. Relations of biomarkers of distinct pathophysiological pathways and atrial fbrillation incidence in the community. Circulation. 2010;121:200-207.
4. Wang TJ, Larson MG, Levy D, Benjamin EJ, Leip EP, Omland T, et al. Plasma natriuretic peptide levels and the risk of cardiovascular events and death. N Engl J Med. 2004;350:655-663.
5. Takahashi T, Nakamura M, Onoda T, Ohsawa M, Tanno K, Itai K, et al. Predictive value of plasma B-type natriuretic peptide for ischemic stroke: a community-based longitudinal study. Atherosclerosis. 2009;207:298-303.
6. Rutten JH, Mattace-Raso FU, Steyerberg EW, Lindemans J, Hofman A, Wieberdink RG, et al. Amino-terminal pro-B-type natriuretic peptide improves cardiovascular and cerebrovascular risk prediction in the population: the Rotterdam study. Hypertension. 2010;55:785-791.
7. Folsom AR, Nambi V, Bell EJ, Oluleye OW, Gottesman RF, Lutsey PL, et al. Troponin T, N-terminal pro-B-type natriuretic peptide, and incidence of stroke: the atherosclerosis risk in communities study. Stroke. 2013;44:961-967.
8. Howard VJ, Kleindorfer DO, Judd SE, McClure LA, Safford MM, Rhodes JD, et al. Disparities in stroke incidence contributing to disparities in stroke mortality. Ann Neurol. 2011;69:619-627.
9. Howard VJ, Cushman M, Pulley L, Gomez CR, Go RC, Prineas RJ, et al. The Reasons for Geographic and Racial Differences in Stroke study: objectives and design. Neuroepidemiology. 2005;25:135-143.
10. Morton LM, Cahill J, Hartge P. Reporting participation in epidemiologic studies: a survey of practice. Am J Epidemiol. 2006;163:197-203.
11. Soliman EZ, Howard G, Prineas RJ, McClure LA, Howard VJ. Calculating Cornell voltage from nonstandard chest electrode recording site in the Reasons for Geographic and Racial Differences in Stroke study. J Electrocardiol. 2010;43:209-214.
12. Pullicino PM, McClure LA, Wadley VG, Ahmed A, Howard VJ, Howard G, et al. Blood pressure and stroke in heart failure in the Reasons for Geographic and Racial Differences in Stroke (REGARDS) study. Stroke. 2009;40:3706-3710.
13. Jones WJ, Williams LS, Meschia JF. Validating the Questionnaire for Verifying Stroke-Free Status (QVSFS) by neurological history and examination. Stroke. 2001;32:2232-2236.
14. Schneider AT, Kissela B, Woo D, Kleindorfer D, Alwell K, Miller R, et al. Ischemic stroke subtypes: a population-based study of incidence rates among blacks and whites. Stroke. 2004;35:1552-1556.
15. Cushman M, McClure LA, Howard VJ, Jenny NS, Lakoski SG, Howard G. Implications of increased C-reactive protein for cardiovascular risk stratifcation in black and white men and women in the US. Clin Chem. 2009;55:1627-1636.
16. Onland-Moret NC, van der A DL, van der Schouw YT, Buschers W, Elias SG, van Gils CH, et al. Analysis of case-cohort data: a comparison of different methods. J Clin Epidemiol. 2007;60:350-355.
17. Pencina MJ, D'Agostino RB Sr, D'Agostino RB Jr, Vasan RS. Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassifcation and beyond. Stat Med. 2008;27:157-172, discussion 207.
18. Choi EY, Bahrami H, Wu CO, Greenland P, Cushman M, Daniels LB, et al. N-terminal pro-B-type natriuretic peptide, left ventricular mass, and incident heart failure: Multi-Ethnic Study of Atherosclerosis. Circ Heart Fail. 2012;5:727-734.
19. Soliman EZ, Howard G, Meschia JF, Cushman M, Muntner P, Pullicino PM, et al. Self-reported atrial fbrillation and risk of stroke in the Reasons for Geographic and Racial Differences in Stroke (REGARDS) study. Stroke. 2011;42:2950-2953.
20. Howard G, Cushman M, Kissela BM, Kleindorfer DO, McClure LA, Safford MM, et al; Reasons for Geographic and Racial Differences in Stroke (REGARDS) Investigators. Traditional risk factors as the underlying cause of racial disparities in stroke: lessons from the half-full (empty?) glass. Stroke. 2011;42:3369-3375.
21. Cannone V, Huntley BK, Olson TM, Heublein DM, Scott CG, Bailey KR, et al. Atrial natriuretic peptide genetic variant rs5065 and risk for cardiovascular disease in the general community: a 9-year follow-up study. Hypertension. 2013;62:860-865.
22. Hijazi Z, Oldgren J, Andersson U, Connolly SJ, Ezekowitz MD, Hohnloser SH, et al. Cardiac biomarkers are associated with an increased risk of stroke and death in patients with atrial fbrillation: a Randomized Evaluation of Long-term Anticoagulation Therapy (RE-LY) substudy. Circulation. 2012;125:1605-1616.
23. Montaner J, Perea-Gainza M, Delgado P, Ribó M, Chacón P, Rosell A, et al. Etiologic diagnosis of ischemic stroke subtypes with plasma bio-markers. Stroke. 2008;39:2280-2287.
24. García-Berrocoso T, Giralt D, Bustamante A, Etgen T, Jensen JK, Sharma JC, et al. B-type natriuretic peptides and mortality after stroke: a systematic review and meta-analysis. Neurology. 2013;81:1976-1985.
25. Longstreth WT Jr, Kronmal RA, Thompson JL, Christenson RH, Levine SR, Gross R, et al. Amino terminal pro-B-type natriuretic peptide, secondary stroke prevention, and choice of antithrombotic therapy. Stroke. 2013;44:714-719.
26. Scheven L, de Jong PE, Hillege HL, Lambers Heerspink HJ, van Pelt LJ, Kootstra JE, et al; PREVEND Study Group. High-sensitive troponin T and N-terminal pro-B type natriuretic peptide are associated with cardiovascular events despite the cross-sectional association with albuminuria and glomerular fltration rate. Eur Heart J. 2012;33:2272-2281.
27. Wang TJ, Gona P, Larson MG, Tofer GH, Levy D, Newton-Cheh C, et al. Multiple biomarkers for the prediction of frst major cardiovascular events and death. N Engl J Med. 2006;355:2631-2639.
28. Olsen MH, Hansen TW, Christensen MK, Gustafsson F, Rasmussen S, Wachtell K, et al. Cardiovascular risk prediction by N-terminal pro brain natriuretic peptide and high sensitivity C-reactive protein is affected by age and sex. J Hypertens. 2008;26:26-34.
29. Melander O, Newton-Cheh C, Almgren P, Hedblad B, Berglund G, Engström G, et al. Novel and conventional biomarkers for prediction of incident cardiovascular events in the community. JAMA. 2009;302:49-57.
30. Shaw LJ, Polk DM, Kahute TA, Wong ND, Moon J, Miranda-Peats R, et al. Prognostic accuracy of B-natriuretic peptide measurements and coronary artery calcium in asymptomatic subjects (from the Early Identifcation of Subclinical Atherosclerosis by Noninvasive Imaging Research [EISNER] study). Am J Cardiol. 2009;104:1245-1250. Stroke